Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities-Reference-Cited by-同舟云学术

Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities

Published:2022-07 Issue:7 Volume:21 Page:645-658
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Tabrizi Sarah J,Estevez-Fraga Carlos,van Roon-Mom Willeke M C,Flower Michael D,Scahill Rachael I,Wild Edward J,Muñoz-Sanjuan Ignacio,Sampaio Cristina,Rosser Anne E,Leavitt Blair R

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference122 articles.

1. Huntingtin-lowering therapies for Huntington disease;Leavitt;JAMA Neurol,2020

2. Huntington disease;Bates;Nat Rev Dis Prim,2015

3. Huntingtin lowering strategies for disease modification in Huntington's disease;Tabrizi;Neuron,2019

4. Therapies targeting DNA and RNA in Huntington's disease;Wild;Lancet Neurol,2017

5. The neuropathology of Huntington's disease: classical findings, recent developments and correlation to functional neuroanatomy;Rüb;Adv Anat Embryol Cell Biol,2015

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging pharmacological approaches for Huntington's disease;European Journal of Pharmacology;2024-10

2. Innovation in nanomedicine: nanocarriers for central nervous system disorders management;International Journal of Polymeric Materials and Polymeric Biomaterials;2024-09-13

3. Tailoring the pK_a of Fluorescence Lifetime Imaging Probes to Visualize Aggrephagy and Resolve Its Microenvironmental Viscosity;Analytical Chemistry;2024-08-22

4. mRNA Nuclear Clustering Leads to a Difference in Mutant Huntingtin mRNA and Protein Silencing by siRNAs In Vivo;Nucleic Acid Therapeutics;2024-08-01

5. Perillaldehyde alleviates polyQ‐induced neurodegeneration through the induction of autophagy and mitochondrial UPR in Caenorhabditis elegans;BioFactors;2024-07-11